Navigation Links
PET/MR Scanner Holds Promise For Expanded Diagnostics
Date:3/7/2013

BOSTON, March 7, 2013 /PRNewswire/ -- Research hospitals worldwide are extolling the virtues of the Philips Healthcare Ingenuity TF PET/MR hybrid whole body scanner, expressing confidence in its potential to better detect liver metastases. Peter Cempellin was head of Nuclear Medicine with Philips Healthcare when he led the engineering design team responsible for the scanner's inception. Cempellin, a mechanical engineer and MBA, devised a way with his team that PET/MR could be cohesively combined to obtain a whole body scan, offering a more precise method to identify and diagnose cancerous tumors than previously available.

"PET identifies cancerous tumors by gathering information about their metabolic rate. MR detects contrasting differences in tissue density.  Together, they comprised a powerful diagnostic tool. Up until this point, the combination was pure conjecture. PET scans had been combined with Computed Tomography (CT), but never MR. It was considered virtually impossible because the PET imaging gantry hardware conflicted with the MR magnetic field. Our approach to a solution was an innovative twist to overcome the formidable technical challenges inherent in PET/MR Hybrid Imaging, accomplishing a near simultaneous PET/MR image and allowing us to get this product to market quickly," explained Cempellin.

The Philips design avoided some of the challenges of a fully integrated MR/PET scanner with the PET gantry inside of the MR bore, so it didn't require years to develop and perfect. Cempellin's insightful management approach accelerated product inception to full-scale rollout with FDA approval of the TF PET/MR whole body scanner, beating the competition to market. The scanner was then nominated for a 2011 Wall Street Journal Technology Innovation Award.

Since 2011 market rollout, some 35 of the world's top research hospitals have added the Ingenuity TF PET/MR hybrid scanner to imaging suites. The scanner shows promise for cardiology. Radiological Society of North America (RSNA) researchers predict its potential for better detection of liver metastases. A market is limitless when you lead by design.

About Peter Cempellin

Cempellin has a track record in conceiving, launching and growing innovative offerings including nuclear medicine, radiology and medical simulation. He is known for identifying unmet clinical needs and a relentless focus on results. During his tenure at Philips Healthcare, Cempellin managed the company's molecular imaging division encompassing positron emission tomography, computed tomography (PET/CT) and magnetic resonance imaging (PET/MR).


'/>"/>
SOURCE Peter Cempellin
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Forschungslabore weltweit führen den neuen 3 Tesla, kyrogenfreien MRI-Arbeitsflächenscanner ein
2. Research Units Across the World go for the First 3 Tesla, Cryogen Free MRI Bench Top Scanner
3. Der NeuViz 64 Multi-Slice-CT-Scanner von Neusoft Medical Systems erhält FDA-Genehmigung
4. The NeuViz 64 Multi-slice CT Scanner from Neusoft Medical Systems Receives FDA Clearance
5. Cost vs. Reality - What CT Scanner Should I Choose?
6. Positrons Attrius PET Scanner Now Utilized In Alzheimers Imaging With Amyvid Agent
7. Global Computed Tomography (CT) Scanners Industry
8. Hamamatsus NanoZoomer whole-slide scanners play a critical role in CSHLs Mouse Brain Architecture Project
9. FDA Clears New Siemens SOMATOM Perspective CT Scanner
10. Neusoft Medical Launches NeuViz 64 Multi-slice CT Scanner at CMEF Spring 2012
11. MetroStar Home Health Products Holds Sandy Relief Holiday Toy Drive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology:
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based ... recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting from ... large range of supplements that keep the body functioning at its peak performance ...
Breaking Medicine News(10 mins):